Living Well on Mounjaro: The Nutrition Guide

Mounjaro turns your appetite down. It does not turn down what your body needs. That gap is where most nutrition problems on a GLP-1 medicine start: too little protein, fibre and fluid, and a diet narrowed to the few foods that still appeal. Get those right and most of the side effects shrink.

• Eat, even when you are not hungry. Skipping food turns mild nausea into headaches, dizziness and exhaustion; how many calories sets the floor
• Protein first. 1.2 to 1.6 g per kilogram of body weight a day, spread across the day
• Fibre and fluid together. Build towards 30 g of fibre with 1.5 to 2 litres of fluid
• Check, don't guess, on vitamins. Vitamin D in winter for everyone; iron and B12 only if a blood test says so
• Plan for stopping before you stop. Appetite returns in weeks; muscle and habits are what you keep. A stall on the way is usually water or portions

Sources checked on 29 October 2026.

Why does food matter more on Mounjaro?

Tirzepatide, the medicine in Mounjaro, acts on two gut hormone receptors, GLP-1 and GIP. It slows the stomach's emptying and tells the brain you are full sooner and for longer.¹ In one manufacturer-funded trial of 30 adults, semaglutide cut intake by about a quarter.²

In the 160-person SURMOUNT-1 body-composition substudy, about three-quarters of the weight lost was fat and a quarter lean tissue, the same proportions as in the placebo group.³ What to eat on Mounjaro and what to avoid cover the food.

How much protein do you need on Mounjaro?

More than the UK reference intake (about 55 g a day for a man and 45 g for a woman), which is set for people who are not losing weight.¹⁵ During deliberate weight loss, 1.2 to 1.6 g per kilogram preserves more lean mass and keeps people fuller.⁴ For a 90 kg person that is 110 to 145 g a day; the protein page has every weight.

Protein first at every meal: 25 to 30 g a sitting, three or four times a day, with a shake when a meal is too much. The supplements guide, including protein, is here.

What should the first few weeks look like?

Side effects cluster in the first one to three days after each dose, when the medicine's level peaks, are most frequent in the dose-increase weeks and ease over time.^{5, 16} Nausea, sulphur burps, heartburn, a dry mouth and a stomach that feels full after four bites are the common ones. The food answers are the same for all of them: small, low-fat, plain, and upright for an hour after eating.

The week-one mistake is to stop eating because you feel sick. An empty stomach on a medicine that slows digestion makes nausea worse. Eat something small every three to four hours. The first week, late-week hunger and eating out have their own pages.

Constipation on Mounjaro: fibre and fluid

Constipation is one of the most reported side effects of GLP-1 medicines, alongside nausea and diarrhoea.⁶ Slower gut movement is the medicine, less coming in is the appetite.

The UK fibre target is 30 g a day; most adults manage around 20 g.⁷ Build up over two to three weeks, favour soluble fibre (oats, beans, lentils, chia, fruit) over bran,⁸ and drink 1.5 to 2 litres of fluid alongside it. Nothing moving for several days, or pain or bleeding, is a pharmacist or GP question.

Tiredness, headaches and feeling cold on Mounjaro

Less food and less fluid produce tiredness, a dull headache and dizziness, the NHS's signs of dehydration;¹⁷ they improve when you eat and drink on a schedule. The NHS says it is best to avoid alcohol while using tirzepatide, because it can worsen nausea and vomiting.¹⁸

If tiredness lasts past the first month, or comes with breathlessness or palpitations, ask your GP for a blood count and iron, B12, folate and vitamin D levels. Tiredness, headaches, feeling cold, sleep and alcohol each have a page, and tiredness on Wegovy its own.

Will you lose muscle on Mounjaro?

Some, unless you act. Resistance exercise two or three times a week during an energy deficit reduces the loss of lean mass compared with dieting alone, and in older adults it largely prevented it.^{9, 10} With 1.2 to 1.6 g of protein per kilogram, it decides what the loss is made of.

Hair loss, skin and Mounjaro face

Hair shedding three to four months after rapid weight loss is common and usually temporary: telogen effluvium, linked to the pace of weight loss, and to protein and iron, more than to the medicine itself.^{11, 12, 20} Check ferritin first, then biotin, which contributes to the maintenance of normal hair; should you take collagen on Mounjaro has its own page.

Mounjaro face or Ozempic face is fat loss from the cheeks and temples. Slower loss and enough protein are the levers; no trial has tested a supplement. Hair loss on Mounjaro is here and the face question is here.

Which vitamins do you actually need?

A 2026 review of six studies in 480,825 adults on GLP-1 medicines found more than 60% of users below their requirements for calcium and iron, mainly from observational data; a narrowed diet is the obvious route.¹³ The list is short: vitamin D at 10 micrograms a day from October to March, as the NHS advises every adult in the UK¹⁹ (the vitamin D guide has the detail); iron or B12 only if a blood test shows you need them; a standard multivitamin if your diet has shrunk to a handful of foods.

Pregnancy and contraception

Mounjaro is not used in pregnancy, and the product information asks women on the pill to use a barrier method for four weeks after starting and after each dose increase.¹⁶ Pregnancy, periods, the pill, HRT and the menopause and PCOS each have a page; the questions women ask brings them together.

What happens when you stop?

Appetite returns within weeks. In the SURMOUNT-4 trial, people switched to a placebo after 36 weeks regained more than half of the weight they had lost over the following year.¹⁴

What you keep is what you built: the muscle, the protein-first habit, the fibre, the smaller plate. No supplement does what the medicine does, and the foods that raise your own GLP-1 matter afterwards. Stopping Mounjaro, including maintenance, is here. Stopping Wegovy or Ozempic is the sister page.

What we don't know

• Long-term nutrient status. The trials ran one to two years and did not measure micronutrients closely.
• The best protein target. The 1.2 to 1.6 g range comes from weight-loss studies without GLP-1 medicines; none has tested protein doses on Mounjaro.
• Hair loss rates. A 2026 review of 24 studies found it reported most with semaglutide and tirzepatide, more in women, but from records and reports, not hair counts.¹²

Frequently asked questions

Is there an official Mounjaro diet?

No. The trials asked only for a reduced-calorie diet and more activity;¹⁶ the seven-day plan puts the advice here on a plate.

Do I need to count calories on Mounjaro?

Usually the opposite: most people need to eat more, not less; the calories page gives the floor.

How much protein do you need on Mounjaro?

1.2 to 1.6 g per kilogram a day, in 25 to 30 g portions; the protein page works it out for your weight.⁴

Sources

1. Bellavance D, et al. Gastrointestinal motility effects of GLP-1 receptor agonists. Current Gastroenterology Reports, 2025. Review; US government work. PubMed 40622491.
2. Blundell J, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 2017. Randomised crossover, 30 adults, 12 weeks; manufacturer-funded. PubMed 28266779.
3. Look M, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study. Diabetes, Obesity and Metabolism, 2025. Scan substudy of a randomised trial, 160 adults, 72 weeks; manufacturer-funded. PubMed 39996356.
4. Leidy HJ, et al. The role of protein in weight loss and maintenance. American Journal of Clinical Nutrition, 2015. Review; funding not stated on PubMed. PubMed 25926512.
5. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022. Randomised trial (SURMOUNT-1), 2,539 adults, 72 weeks; manufacturer-funded. PubMed 35658024.
6. Ismaiel A, et al. Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis. International Journal of Obesity, 2025. Pooled analysis, 39 studies, 33,354 people; no competing interests. PubMed 40804463.
7. NHS. How to get more fibre into your diet. Page last reviewed 2 March 2026. nhs.uk.
8. Dimidi E, et al. British Dietetic Association guidelines for the dietary management of chronic constipation in adults. Journal of Human Nutrition and Dietetics, 2025. Guideline from pooled analyses of 75 randomised trials; dietetic association funding, authors declare industry fees. PubMed 41081513.
9. Sardeli AV, et al. Resistance training prevents muscle loss induced by caloric restriction in obese elderly individuals: a systematic review and meta-analysis. Nutrients, 2018. Pooled analysis, 6 randomised trials, 12 to 24 weeks; no conflicts declared. PubMed 29596307.
10. Binmahfoz A, et al. Effect of resistance exercise on body composition, muscle strength and cardiometabolic health during dietary weight loss: a systematic review and meta-analysis. BMJ Open Sport and Exercise Medicine, 2025. Pooled analysis, 25 randomised trials; none declared. PubMed 40909191.
11. Chien Yin GO, et al. Telogen effluvium: a review of the science and current obstacles. Journal of Dermatological Science, 2021. Review; no funding or conflicts listed on PubMed. PubMed 33541773.
12. Gupta AK, et al. GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling. Science Progress, 2026. Systematic review, 24 studies; one author reports industry trial grants. PubMed 41998799.
13. Urbina J, et al. Micronutrient and nutritional deficiencies associated with GLP-1 receptor agonist therapy: a narrative review. Clinical Obesity, 2026. Review, 6 studies, 480,825 adults, mainly observational; no funding listed on PubMed. PubMed 41549912.
14. Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA, 2024. Randomised withdrawal trial, 670 adults, 52 weeks after a 36-week lead-in; manufacturer-funded. PubMed 38078870.
15. Public Health England. Government dietary recommendations, 2016 (Eatwell Guide page, updated 2 January 2024). gov.uk.
16. Tirzepatide. Summary of Product Characteristics, sections 4.5, 4.6, 4.8, 5.1 and 5.2 (peak level 8 to 72 hours after a dose). Date of revision of the text 29 August 2026. medicines.org.uk.
17. NHS. Dehydration. Page last reviewed 1 May 2026. nhs.uk.
18. NHS. Tirzepatide. Page last reviewed 15 May 2026. nhs.uk.
19. NHS. Vitamin D. Page last reviewed 3 August 2020 (review overdue). nhs.uk.
20. Malkud S. Telogen effluvium: a review. Journal of Clinical and Diagnostic Research, 2015. Narrative review; funding not stated on PubMed. PubMed 26500992.

Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.

This article is general information, not medical advice. Mounjaro is a prescription medicine: follow your prescriber's instructions and speak to your GP or pharmacist before starting a supplement.